NL-OMON34088已完成不适用
Pharmacokinetics in Plasma and Saliva of a Single Dose Immediate- or Extended-Release Methylphenidate in Healthy Volunteers. - MPH PK in healthy volunteers.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •18-35 years of age
- •BMI 18-30 kg/m2, body weight 50-90 kg
排除标准
- •Pregancy or breast feeding
- •Alcohol or substance abuse
- •Smoking > 5 cig/day
- •Previous exposure to stimulant compounds past 6 months
- •Disallowed concomittant medication within one week from first study day
研究者
相似试验
已完成
不适用
Pharmacokinetics in Plasma and Saliva of a Single Dose Caffeine in Healthy Volunteers/ANL-OMON37682Centre for Human Drug Research6
进行中（未招募）
不适用
Pharmacokinetics in Plasma and Saliva of a Single Dose Immediate- or Extended Release Methylphenidate in Healthy Volunteers. - MPH PK in adults./Apharmacokinetic study.Methylphenidate is indicated in ADHD and narcolepsia.EUCTR2010-020014-28-NLCentre for Human Drug Research12
进行中（未招募）
不适用
Pharmacokinetics of orally aministered single doses (40-60-80 mcg) of T3sulfate-sodium salt (T3S)Healthy subjects (hypothyroidism)MedDRA version: 14.0Level: PTClassification code 10021114Term: HypothyroidismSystem Organ Class: 10014698 - Endocrine disordersEUCTR2011-000824-14-ITBRACCO24
未知
1 期
TJ-100 Pharmacokinetic studyHealthy volunteersJPRN-jRCT1080221080Tsumura & Co.15
未知
1 期
TJ-54 Pharmacokinetic studyHealthy volunteersJPRN-jRCT1080221769Tsumura & Co.15